ArticleAnnals of hematology2024

Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.

Jiawen Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.